Print PDF
Interview on the FDA’s Emergency Use Authorization Process for COVID-19 Vaccines
March 2021
Pharmacy Times

Axinn partner Chad Landmon participated in a three part video interview with Pharmacy Times. They discussed the FDA’s emergency use authorization (EUA) process for COVID-19 vaccines, such as the expedited process for the recently authorized Johnson & Johnson COVID-19 vaccine. Click below to access the interview.

Part 1: "How the FDA’s Expedited EUA Process for COVID-19 Vaccines Works"
Part 2: "How to Discuss the FDA’s Expedited EUA Process with Vaccine Hesitant Patients"
Part 3: "How the COVID-19 Pandemic Has Impacted the FDA’s Approval Process"

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.